Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+43.4%
5Y CAGR+80.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+43.4%/yr
vs +81.3%/yr prior
5Y CAGR
+80.7%/yr
Recent deceleration
Acceleration
-37.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
19.3x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $19.38M | +60.1% |
| 2024 | $12.10M | +41.6% |
| 2023 | $8.55M | +30.2% |
| 2022 | $6.57M | +126.7% |
| 2021 | $2.90M | +188.3% |
| 2020 | $1.00M | -14.0% |
| 2019 | $1.17M | +92.1% |
| 2018 | $608000.00 | - |